Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02818712
What this trial is testing

Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up

Who this might be right for
Idiopathic Pulmonary Fibrosis
Aarhus University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Not applicableUnknownNCT05514522
What this trial is testing

The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.

Who this might be right for
Interstitial Lung DiseaseSARS-CoV-2 Infection
Imperial College London 2,000
Large-scale testing (Phase 3)Study completedNCT03018041
What this trial is testing

The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

Who this might be right for
Kidney Transplantation
Joe Chan 174
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT04396756
What this trial is testing

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT04533022
What this trial is testing

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vicore Pharma AB 52
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Large-scale testing (Phase 3)Looking for participantsNCT06125327
What this trial is testing

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 210
Not applicableStudy completedNCT02665546
What this trial is testing

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Who this might be right for
Langerhans Cell Histiocytosis
InCor Heart Institute 35
Testing effectiveness (Phase 2)Study completedNCT02846324
What this trial is testing

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Global Blood Therapeutics 39
Post-approval studies (Phase 4)Study completedNCT02579603
What this trial is testing

Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 105
Early research (Phase 1)Looking for participantsNCT06581562
What this trial is testing

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Who this might be right for
Rheumatoid ArthritisPemphigus VulgarisGranulomatosis With Polyangiitis+1 more
IRIS Research and Development, LLC 30
Not applicableUnknownNCT05095090
What this trial is testing

Study of Hospitalised Patients With Acute Respiratory Conditions

Who this might be right for
Acute Respiratory DiseaseCOPD Exacerbation AcuteAsthma+1 more
University of Leicester 130
Early research (Phase 1)UnknownNCT06482190
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd 72
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 103
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Study completedNCT00189176
What this trial is testing

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 23
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01750697
What this trial is testing

A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Who this might be right for
Granulomatosis With Polyangiitis
Hoffmann-La Roche 25
Next Page